Codexis to Participate in Jefferies Global Healthcare Conference
REDWOOD CITY, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading enzyme engineering company, today announced the Company will attend the Jefferies Global Healthcare Conference, being held
Codexis to Participate in TD Cowen 2nd Annual Sustainability Week
REDWOOD CITY, Calif., May 20, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading enzyme engineering company, today announced the Company will participate in a panel discussion titled, "Sustainable API
Stifel Nicolaus Reaffirms Their Buy Rating on Codexis (CDXS)
Express News | Codexis Inc -May Offer & Sell Shares of Common Stock Having an Aggregate Offering Price of up to $75 Mln From Time to Time Through or to Cantor
Express News | Codexis Inc - Entered Into Controlled Equity Offering Sales Agreement Relating to Sale of Shares of Common Stock
Codexis (CDXS) Gets a Buy From Craig-Hallum
Express News | Codexis Successfully Synthesizes An Oligonucleotide Via An Enzymatic Route To Support RNA-Based Therapeutics Manufacturing
Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting
REDWOOD CITY, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading enzyme engineering company, today announced it has successfully synthesized an oligonucleotide via an enzymatic route to
Is Codexis (NASDAQ:CDXS) Using Too Much Debt?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' So it seems the smart money knows that debt - which is usu
Codexis First Quarter 2024 Earnings: Beats Expectations
Express News | Benchmark Reiterates Buy on Codexis, Maintains $9 Price Target
Codexis Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/03/2024 127.27% Benchmark → $9 Reiterates Buy → Buy 02/29/2024 127.27% Benchmark → $9 Upgrades Hold → B
Express News | Codexis Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results
Earnings Call Summary | Codexis(CDXS.US) Q1 2024 Earnings Conference
The following is a summary of the Codexis, Inc. (CDXS) Q1 2024 Earnings Call Transcript:Financial Performance:Codexis reported Q1 2024 total revenues of $17.1 million, an increase of 32% year-over-yea
Benchmark Co. Sticks to Their Buy Rating for Codexis (CDXS)
Q1 2024 Codexis Inc Earnings Call
Express News | Codexis Shares up 10.2% Premarket After Q1 Results
Codexis Inc (CDXS) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
Codexis, Inc. (CDXS) Q1 2024 Earnings Call Transcript
Codexis, Inc. (CDXS) Q1 2024 Earnings Call Transcript
Codexis Inc (CDXS) Q1 2024 Earnings: Surpasses Revenue Forecasts With Strategic Advances